Creatine Supplementation and Exercise as Possible Therapeutic Treatments in Parkinson’s Disease: A Review

Scott Murray Graham, Marianne F Baird, Gary W Boyd

Research output: Contribution to journalArticle

Abstract

Parkinson’s disease (PD) is the second most common progressive neurodegenerative condition after Alzheimer’s Disease. It is characterized by a progressive loss of dopaminergic neurons in the substantia nigra region of the brain. Symptoms and signs manifest as motor disorders affecting balance and physical capacity, and non-motor symptoms such as cognitive decline and mood disorders. People with PD face considerable difficulties coping with associated physical and psychological changes which affect their quality of life. The main form of treatment is pharmacological which alleviates some of the symptoms but does not slow the progression of the disease. Creatine monohydrate (Cr) may have therapeutic benefits in conditions where energy dysfunction and high rates of apoptosis are present. Cr supplementation may provide a protective effect by augmenting cytosolic high energy phosphate stores thereby prolonging the survival of ‘at risk’ cells in neurodegenerative diseases. Emerging evidence suggests supplementation may offer specific benefits in the treatment of mood disorders associated with PD. Many different types of exercise have shown efficacy in enhancing physical capacity, balance and quality of life. Recently, research has demonstrated the potential benefits of diverse modes of exercise such as aquatic exercise and boxing in PD. Combining exercise with Cr supplementation can enhance exercise induced muscular strength and power adaptations and may further improve exercise capacity and neuromuscular function. This review will critique evidence relating to the potential efficacy of Cr supplementation and exercise as a putative therapeutic approach in the treatment of the physiological and psychological challenges presented by PD.
Original languageEnglish
JournalArchives of Exercise in Health and Disease
Volume4
Issue number3
Publication statusPublished - 2014

Fingerprint

Creatine
Parkinson Disease
Mood Disorders
Quality of Life
Boxing
Psychology
Therapeutics
Dopaminergic Neurons
Substantia Nigra
Neurodegenerative Diseases
Signs and Symptoms
Disease Progression
Alzheimer Disease
Phosphates
Pharmacology
Apoptosis
Brain
Research

Cite this

@article{434b6dedd8dc4231922433d586b3055e,
title = "Creatine Supplementation and Exercise as Possible Therapeutic Treatments in Parkinson’s Disease: A Review",
abstract = "Parkinson’s disease (PD) is the second most common progressive neurodegenerative condition after Alzheimer’s Disease. It is characterized by a progressive loss of dopaminergic neurons in the substantia nigra region of the brain. Symptoms and signs manifest as motor disorders affecting balance and physical capacity, and non-motor symptoms such as cognitive decline and mood disorders. People with PD face considerable difficulties coping with associated physical and psychological changes which affect their quality of life. The main form of treatment is pharmacological which alleviates some of the symptoms but does not slow the progression of the disease. Creatine monohydrate (Cr) may have therapeutic benefits in conditions where energy dysfunction and high rates of apoptosis are present. Cr supplementation may provide a protective effect by augmenting cytosolic high energy phosphate stores thereby prolonging the survival of ‘at risk’ cells in neurodegenerative diseases. Emerging evidence suggests supplementation may offer specific benefits in the treatment of mood disorders associated with PD. Many different types of exercise have shown efficacy in enhancing physical capacity, balance and quality of life. Recently, research has demonstrated the potential benefits of diverse modes of exercise such as aquatic exercise and boxing in PD. Combining exercise with Cr supplementation can enhance exercise induced muscular strength and power adaptations and may further improve exercise capacity and neuromuscular function. This review will critique evidence relating to the potential efficacy of Cr supplementation and exercise as a putative therapeutic approach in the treatment of the physiological and psychological challenges presented by PD.",
author = "Graham, {Scott Murray} and Baird, {Marianne F} and Boyd, {Gary W}",
year = "2014",
language = "English",
volume = "4",
journal = "Archives of Exercise in Health and Disease",
issn = "1647-1652",
publisher = "University of Porto",
number = "3",

}

Creatine Supplementation and Exercise as Possible Therapeutic Treatments in Parkinson’s Disease : A Review. / Graham, Scott Murray; Baird, Marianne F; Boyd, Gary W.

In: Archives of Exercise in Health and Disease, Vol. 4, No. 3, 2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Creatine Supplementation and Exercise as Possible Therapeutic Treatments in Parkinson’s Disease

T2 - A Review

AU - Graham, Scott Murray

AU - Baird, Marianne F

AU - Boyd, Gary W

PY - 2014

Y1 - 2014

N2 - Parkinson’s disease (PD) is the second most common progressive neurodegenerative condition after Alzheimer’s Disease. It is characterized by a progressive loss of dopaminergic neurons in the substantia nigra region of the brain. Symptoms and signs manifest as motor disorders affecting balance and physical capacity, and non-motor symptoms such as cognitive decline and mood disorders. People with PD face considerable difficulties coping with associated physical and psychological changes which affect their quality of life. The main form of treatment is pharmacological which alleviates some of the symptoms but does not slow the progression of the disease. Creatine monohydrate (Cr) may have therapeutic benefits in conditions where energy dysfunction and high rates of apoptosis are present. Cr supplementation may provide a protective effect by augmenting cytosolic high energy phosphate stores thereby prolonging the survival of ‘at risk’ cells in neurodegenerative diseases. Emerging evidence suggests supplementation may offer specific benefits in the treatment of mood disorders associated with PD. Many different types of exercise have shown efficacy in enhancing physical capacity, balance and quality of life. Recently, research has demonstrated the potential benefits of diverse modes of exercise such as aquatic exercise and boxing in PD. Combining exercise with Cr supplementation can enhance exercise induced muscular strength and power adaptations and may further improve exercise capacity and neuromuscular function. This review will critique evidence relating to the potential efficacy of Cr supplementation and exercise as a putative therapeutic approach in the treatment of the physiological and psychological challenges presented by PD.

AB - Parkinson’s disease (PD) is the second most common progressive neurodegenerative condition after Alzheimer’s Disease. It is characterized by a progressive loss of dopaminergic neurons in the substantia nigra region of the brain. Symptoms and signs manifest as motor disorders affecting balance and physical capacity, and non-motor symptoms such as cognitive decline and mood disorders. People with PD face considerable difficulties coping with associated physical and psychological changes which affect their quality of life. The main form of treatment is pharmacological which alleviates some of the symptoms but does not slow the progression of the disease. Creatine monohydrate (Cr) may have therapeutic benefits in conditions where energy dysfunction and high rates of apoptosis are present. Cr supplementation may provide a protective effect by augmenting cytosolic high energy phosphate stores thereby prolonging the survival of ‘at risk’ cells in neurodegenerative diseases. Emerging evidence suggests supplementation may offer specific benefits in the treatment of mood disorders associated with PD. Many different types of exercise have shown efficacy in enhancing physical capacity, balance and quality of life. Recently, research has demonstrated the potential benefits of diverse modes of exercise such as aquatic exercise and boxing in PD. Combining exercise with Cr supplementation can enhance exercise induced muscular strength and power adaptations and may further improve exercise capacity and neuromuscular function. This review will critique evidence relating to the potential efficacy of Cr supplementation and exercise as a putative therapeutic approach in the treatment of the physiological and psychological challenges presented by PD.

M3 - Article

VL - 4

JO - Archives of Exercise in Health and Disease

JF - Archives of Exercise in Health and Disease

SN - 1647-1652

IS - 3

ER -